Volunteer without treatment clinical trials

Vitiligo Treatment by Targeting TYK2 Mediated Responses

This study is testing a new medicine called deucravacitinib for vitiligo. It aims to see if it can stop vitiligo from spreading and help skin regain its colour, especially when combined with light therapy.